Authors
UK Prospective Diabetes Study (UKPDS) Group
Publication date
1998/9/12
Journal
The lancet
Volume
352
Issue
9131
Pages
837-853
Publisher
Elsevier
Description
BACKGROUND
Improved blood-glucose control decreases the progression of diabetic microvascular disease, but the effect on macrovascular complications is unknown. There is concern that sulphonylureas may increase cardiovascular mortality in patients with type 2 diabetes and that high insulin concentrations may enhance atheroma formation. We compared the effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial.
METHODS
3867 newly diagnosed patients with type 2 diabetes, median age 54 years (IQR 48–60 years), who after 3 months' diet treatment had a mean of two fasting plasma glucose (FPG) concentrations of 6·1–15·0 mmol/L were randomly assigned intensive policy with a sulphonylurea (chlorpropamide, glibenclamide, or …
Total citations
Scholar articles
UK Prospective Diabetes Study (UKPDS) Group - The lancet, 1998